Position
Principal
Company
Harmony Biosciences
Plymouth MeetingBiotechnologyHealth CareMedicalTherapeuticsBiopharmaDescription
Harmony Biosciences Holdings has named Stephen Mollichella as interim Principal Financial Officer following the resignation of Chief Financial Officer Glenn Reicin. The appointment is effective upon Reicin's departure and helps maintain continuity in the finance leadership.
Quick answer
Harmony Biosciences Appoints Stephen Mollichella as Interim CFO (July 23, 2026). Harmony Biosciences is based in Plymouth Meeting, Pennsylvania, United States.
- Who is the new Principal at Harmony Biosciences?
- Harmony Biosciences named Stephen Mollichella Principal, announced July 23, 2026.
- What did Harmony Biosciences announce on July 23, 2026?
- Harmony Biosciences Holdings has named Stephen Mollichella as interim Principal Financial Officer following the resignation of Chief Financial Officer Glenn Reicin. The appointment is effective upon Reicin's departure and helps maintain continuity in the finance leadership.
- What does Harmony Biosciences do?
- At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook.
- Where is Harmony Biosciences based?
- Harmony Biosciences is based in Plymouth Meeting, Pennsylvania, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (June 17, 2026), Acrivon Therapeutics (August 31, 2026), Verdiva Bio (July 23, 2026) and Ascidian Therapeutics (July 21, 2026) also announced leadership changes within 45 days of Harmony Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries (June 17, 2026)
- Acrivon Appoints Michaela Levin as Chief Business Officer (August 31, 2026)
- Verdiva Bio Appoints Steve Marso as Chief Medical Officer (July 23, 2026)
- Ascidian Therapeutics Appoints Daniel Rosan as President (July 21, 2026)
- Kalaris Therapeutics Appoints Liisa Bayko as Chief Financial Officer (July 20, 2026)
- Imugene Limited Announces Resignation of CEO Leslie Chong Effective Immediately (July 27, 2026)
Who to call at Harmony Biosciences, and when
A new leader at Harmony Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Harmony Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Harmony Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Harmony Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Harmony Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Harmony Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.